CANDIDO, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 4.037
EU - Europa 1.850
AS - Asia 789
SA - Sud America 28
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 6.732
Nazione #
US - Stati Uniti d'America 4.008
PL - Polonia 576
SE - Svezia 358
IT - Italia 340
CN - Cina 264
HK - Hong Kong 236
UA - Ucraina 231
SG - Singapore 116
FI - Finlandia 90
TR - Turchia 76
BG - Bulgaria 47
GB - Regno Unito 47
IE - Irlanda 43
DE - Germania 36
KR - Corea 23
BE - Belgio 18
FR - Francia 17
IN - India 15
BR - Brasile 14
CZ - Repubblica Ceca 13
MX - Messico 13
JP - Giappone 12
CA - Canada 11
AU - Australia 8
EU - Europa 8
SN - Senegal 8
TW - Taiwan 7
VN - Vietnam 7
CO - Colombia 6
ES - Italia 6
HR - Croazia 6
PK - Pakistan 6
RU - Federazione Russa 6
EC - Ecuador 5
IR - Iran 5
ID - Indonesia 4
NI - Nicaragua 4
NL - Olanda 4
CH - Svizzera 3
NP - Nepal 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
EG - Egitto 2
GR - Grecia 2
IQ - Iraq 2
JO - Giordania 2
LB - Libano 2
PH - Filippine 2
SI - Slovenia 2
TH - Thailandia 2
AT - Austria 1
CL - Cile 1
CR - Costa Rica 1
MY - Malesia 1
NO - Norvegia 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TG - Togo 1
ZA - Sudafrica 1
Totale 6.732
Città #
Warsaw 565
Ann Arbor 532
Woodbridge 491
Fairfield 454
Houston 428
Chandler 372
Ashburn 295
Hong Kong 236
Seattle 227
Jacksonville 206
Wilmington 200
Cambridge 152
Princeton 78
Beijing 74
Izmir 66
Trieste 59
Singapore 56
Boardman 55
Sofia 43
Dublin 40
Dearborn 36
Shanghai 25
San Diego 23
Helsinki 20
Brussels 18
Rome 16
Seoul 16
Segrate 13
Venice 13
Jinan 12
Columbus 11
Falls Church 11
Mestre 11
Brno 10
Phoenix 10
Chicago 9
Milan 9
Padova 9
Dakar 8
Kocaeli 8
Redmond 8
Dongguan 7
Düsseldorf 7
Nanjing 7
Pune 7
St. Catharines 7
Venezia 7
Dong Ket 6
Los Angeles 6
Manchester 6
Norwalk 6
Shenyang 6
Washington 6
Zagreb 6
Berlin 5
Buffalo 5
Chengdu 5
Fuzhou 5
Guangzhou 5
Hebei 5
Kunming 5
Lodz 5
Messina 5
Milpa Alta 5
Zacatecas City 5
Zhengzhou 5
Bari 4
Managua 4
Munich 4
Nanchang 4
Quito 4
Santiago de Cali 4
Sydney 4
São Paulo 4
Tokyo 4
Torviscosa 4
Calcinaia 3
Des Moines 3
Fremont 3
Germantown 3
Jakarta 3
Kathmandu 3
Krakow 3
Kyustendil 3
Monfalcone 3
Montreal 3
Moscow 3
Naples 3
Okayama 3
Poznan 3
Redwood City 3
San Francisco 3
Taipei 3
Taizhou 3
Taoyuan District 3
Tehran 3
Tianjin 3
Verona 3
Adelaide 2
Amman 2
Totale 5.179
Nome #
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease 341
A new ultrasonographic instrument for measuring vessel wall shear stress. 339
Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients 318
Large-artery hemodynamics after acute alcohol administration in young, healthy volunteers 222
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 190
Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes. 183
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 182
TRAIL shows potential cardioprotective activity. 178
Angiotensin 1-7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro 177
Haemoconcentration, shear-stress increase and carotid artery diameter regulation after furosemide administration in older hypertensives 170
Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system 164
Cardiac and nephroprotective effects of angiotensin converting enzyme inhibitor treatment in the renal ablation model. 164
TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation 162
Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure. 161
Mechanics of the carotid artery wall and baroreflex sensitivity after acute ethanol administration in young healthy volunteers 149
Strategies used by Patients with Type 1 Diabetes to Avoid Hypoglycemia in a 24×1-Hour Marathon: Comparison with the Amounts of Carbohydrates Estimated by a Customizable Algorithm 149
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 140
ACE2 deficiency shifts energy metabolism towards glucose utilization 138
Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB 138
Endothelial dysfunction (ED) in familial hypercholesterolemia (FH). Role of the LDL-cholesterol (LDL) variations after LDL-aphaeresis (LDL-A) vs medical therapy 134
Comparative effects of antihypertensive and/or antioxidative treatment in an experimental model of chronic progressive nephrosis 134
Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy 133
Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats 133
Contribution of Systemic Blood-pressure To Myocardial Remodeling In Uremic Rats 130
Effects of prolonged high-altitude exposure on peripheral adrenergic receptors in young healthy volunteers. 127
Haemoconcentration, shear-stress elevation and carotid artery diameter regulation after furosemide in older hypertensives 126
Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. 123
null 120
Hypertension and diabetes: emphasis on the renin-angiotensin system in atherosclerosis 116
Does renal function influence the prognostic impact of type 2 diabetes mellitus in patients with chronic heart failure and left ventricular dysfunction? 116
Linking diabetes and atherosclerosis 114
Regional and systemic haemodynamic response to aortography in hypertensives. 113
Effects of central alpha 2-adrenergic agonists on systemic haemodynamics and on baroreceptor reflex sensitivity in spontaneously hypertensive rats. 112
Angiotensin II promotes apoptosis in ventricular cardiomyoctes in vivo 98
Effects of glucose-lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta-analysis of randomized controlled trials with external adjudication of events 89
In vivo effects of fluvastatin on leukocyte vascular trafficking under experimental acute inflammatory conditions 89
Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive doses of an ACE inhibitor 79
Forearm endothelial dysfuncion (ED) is a marker of the epato-renal vascular impairment but not of the systemic haemodynamic control in cirrhotic patients 77
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 60
Type 1 diabetes is associated with significant changes of ACE and ACE2 expression in peripheral blood mononuclear cells 56
Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials. 54
Personalized Approach for the Management of Exercise-Related Glycemic Imbalances in Type 1 Diabetes: Comparison with Reference Method 52
Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents 50
Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive dosages of an ACE inhibitor 47
Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials 44
Deep-learning-based prognostic modeling for incident heart failure in patients with diabetes using electronic health records: a retrospective cohort study 37
Preliminary Study on the Effect of a Night Shift on Blood Pressure and Clock Gene Expression 30
Safety and Appropriateness in the Management of the Treatment Pathway of Pregnant Women with Gestational Diabetes 29
Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials 27
Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population 26
Effect of insulin secretagogues on major cardiovascular events and all-cause mortality: A meta-analysis of randomized controlled trials. 26
An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience 25
Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice 24
Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials 24
ACE-inhibitor treatment prevents cardiac remodelling in experimental uremia 23
Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study 22
A new ultrasonographic instrument for measuring vessel wall shear stress: comparison to a mathematical model in essential hypertensives 22
Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey 21
L'enzima di conversione dell'angiotensina 2 regola il metabolismo glucidico 21
Italian guidelines for the treatment of type 2 diabetes 21
AMD Annals: a model of continuous monitoring and improvement of the quality of diabetes care 20
La territorializzazione del farmaco in epoca di PNRR: prospettive, opportunità e spunti di riflessione da un panel di esperti 20
Sinergia collaborativa nella gestione del paziente diabetico con recente sindrome coronarica acuta 19
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus 19
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products 18
Uncovering Predictors of Lipid Goal Attainment in Type 2 Diabetes Outpatients Using Logic Learning Machine: Insights from the AMD Annals and AMD Artificial Intelligence Study Group 18
A new ultrasonographic instrument for measuring vessel wall shear stress: Comparison to a mathematical model in essential hypertensives 18
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis 18
Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies 17
ACE inhibitors (ACEI) prevent an early albumin permeability defect in isolated glomeruli from streptozotocin-treated rats 17
2023 update on Italian guidelines for the treatment of type 2 diabetes 17
The AMD ANNALS: A continuous initiative for the improvement of type 2 diabetes care 17
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials 17
ACE inhibitor treatment prevents cardiac programmed cell death and intermyocardiocytic fibrosis in hypertensive diabetic rats 16
A new ultrasonographic instrument for measuring vessel wall shear stress: comparison to a mathematical model in essential hypertensives 16
Clinical Inertia Is the Enemy of Therapeutic Success in the Management of Diabetes and Its Complications: A Narrative Literature Review 15
Italian guidelines for the treatment of type 2 diabetes 15
Disfunzione diastolica e diabete 15
Ace Inhibitor treatment prevents renal growth and hyperfiltration in streptozotocin diabetic rats 13
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes 12
ACE inhibitors (ACEI) prevent an early albumin permeability defect in isolated glomeruli from streptozotocin-treated rats 12
Acarbose vs metformin for new-onset type 2 diabetes 11
Aminoguanidine ameliorates diabetes-associated atherosclerosis in apolipoprotein-E KO mice 11
Gestational diabetes mellitus: Impact of adherence on patient management and maternal-neonatal complications 10
Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes 10
An early albumin permeability defect is prevented by strict glycemic control in incipient diabetic nephropathy 10
Disfunzione endoteliale: obiettivo terapeutico primario nel diabete 10
Impiego di associazioni precostituite di ACE-inibitori e sartani in diabetologia: presente e futuro 9
Analysis of left atrial performance in patients with type 2 diabetes mellitus without overt cardiac disease and inducible ischemia: high prevalence of increased systolic force related to enhanced left ventricular systolic longitudinal function 9
Alterazioni del tessuto adiposo, del metabolismo lipidico e delle adipochine nella sindrome metabolica (SM) 8
Appropriatezza prescrittiva di ACE-Inibitori e sartani 8
Oltre l'anno 2000: una rivoluzione per ACE-inibitori e sartani. Dai grandi trial alle nuove strategie terapeutiche 6
Dalla Best Clinical Practice all'appropriatezza e sostenibilità dell'impiego di ACE-I e Sartani in Diabetologia 5
Ruolo della resistenza insulinica nelle malattie vascolari 5
Vasoactive peptides and the kidney 5
Vasoactive peptides and the kidney 4
Il danno renale alla luce delle nuove Linee Guida ESH/ESC 2007 4
Il trial clinico: dai grandi numeri al singolo individuo 4
Lo stress ossidativo nella pratica clinica: come, dove e quando 4
Systemic osteoprotegerin delivery shows pro-atherosclerotic activity in diabetic apolipoprotein E-null mice 3
Totale 7.054
Categoria #
all - tutte 20.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.572


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.482 96 76 61 229 98 176 139 174 160 157 75 41
2020/2021744 62 59 49 100 62 76 46 58 34 102 28 68
2021/2022544 20 28 17 48 17 53 29 12 57 60 47 156
2022/2023981 70 113 85 131 98 183 3 92 137 14 41 14
2023/20241.267 41 232 67 55 99 77 190 138 22 27 152 167
2024/202546 46 0 0 0 0 0 0 0 0 0 0 0
Totale 7.080